You are using an outdated browser. Please upgrade your browser to use this site.

iCleanse Announces Collaboration with CIT to Offer Low-Interest Financing on All iCleanse Disinfection Products
Offering Financing will Help Small & Large Businesses Alike Purchase iCleanse UV-C Disinfection Units to Keep Customers & Staff Safe and Businesses Open
iCleanse Products Kill 99.9% of Infectious Pathogens, such as COVID-19, Influenza and the Common Cold in as Little as 15 Seconds
Wednesday, April 28, 2021 10:00 AM

Avon, CT, April 28, 2021 – iCleanse www.icleanse.com, the leader in UV-C personal device disinfection, announced today that it has joined forces with CIT, a top 50 national bank, to provide low-interest financing on all iCleanse disinfection products to keep customers and staff safe from infectious pathogens. This alliance allows iCleanse to better serve its current and future customer base, who may have limited cash flow due to the year-long pandemic, making UV-C disinfection more attainable for small and large businesses alike and keeping businesses open. iCleanse products kill 99.9% of infectious pathogens, such as COVID-19, the common cold, and influenza in as little as 15 seconds.

iCleanse’s Mission: Help Businesses Remain Safe and Open

iCleanse is the leader and only patented solution in chemical-free UV-C disinfection for mobile devices. Providing quick and effective disinfection for all types of business to help them remain safe and open is the main objective in iCleanse’s mission. Applying for financing through CIT is quick and easy, and customers can receive a decision on financing often in less than three minutes.

“Being able to offer our customers an easy financial solution to purchase our products is a no-brainer,” said Chris Allen, CEO of iCleanse. “Ensuring easy and effective disinfection of the items we use daily is one way to reduce the spread of the COVID-19 pandemic.”

About iCleanse  

iCleanse (formerly ReadyDock) is trusted by over 100 U.S. hospitals. The company’s chemical-free UV-C technology kills pathogens, like the flu, common cold, and COVID-19*. Designed with businesses, employees, customers, and patients in mind, iCleanse offers a wide range of products for every workflow. iCleanse products disinfect high touch surfaces, such as mobile phones and tablets, as well as stethoscopes, ID badges, keycards, and many other items used daily. With the power of iCleanse UV-C disinfection units, users can disinfect devices in less than 30 seconds with 99.9% of infectious pathogens killed. Mess-free, only ultraviolet light (no liquid) is used in the disinfecting process. For more information, please visit: https://icleanse.com.  

About CIT

CIT is a leading national bank focused on empowering businesses and personal savers with the financial agility to navigate their goals. CIT Group Inc. (NYSE: CIT) is a financial holding company with over a century of experience and operates a principal bank subsidiary, CIT Bank, N.A. (Member FDIC, Equal Housing Lender). The company’s commercial banking segment includes commercial financing, community association banking, middle market banking, equipment and vendor financing, factoring, railcar financing, treasury and payments services, and capital markets and asset management. CIT’s consumer banking segment includes a national direct bank and regional branch network. Discover more at cit.com/about.

iCleanse Company Contact:  
Chelsey Clapper, iCleanse at chelseyclapper@icleanse.com  

iCleanse Agency Contact:  
Karen Thomas/Eva Yutani, Thomas PR 
(631) 549-7575 
Emails: kthomas@thomaspr.com / eyutani@thomaspr.com 
Website: http://www.thomasprsocial.com  

*iCleanse is tested for COVID-19 through Surrogate OC43.